Vanguard Personalized Indexing Management, LLC Invitae Corp Transaction History

Vanguard Personalized Indexing Management, LLC

  • $4.59 Billion
  • Q1 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$0.6 - $1.53 $10,911 - $27,823
18,185 New
18,185 $10,000
Q2 2022

Aug 09, 2022
SELL
$2.13 - $9.01 $28,111 - $118,913
-13,198 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$6.28 - $15.59 $58,686 - $145,688
-9,345 Reduced 41.45%
13,198 $105,000
Q4 2021

Feb 23, 2022
BUY
$14.7 - $28.67 $194,128 - $378,616
13,206 Added 141.44%
22,543 $344,000
Q3 2021

Nov 09, 2021
BUY
$24.31 - $33.6 $23,556 - $32,558
969 Added 11.58%
9,337 $265,000
Q2 2021

Aug 11, 2021
BUY
$26.09 - $40.4 $218,321 - $338,067
8,368 New
8,368 $282,000

Others Institutions Holding NVTA

# of Institutions
56
Shares Held
7.66M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Vanguard Personalized Indexing Management, LLC Portfolio

Follow Vanguard Personalized Indexing Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Personalized Indexing Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Personalized Indexing Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email